Suppr超能文献

关于超声造影剂安全使用的多学会专家共识声明。

Multi-societal expert consensus statement on the safe administration of ultrasound contrast agents.

作者信息

Strom Jordan B, Appis Andrew, Barr Richard G, Chammas Maria Cristina, Clevert Dirk-André, Darge Kassa, Feinstein Linda, Feinstein Steven B, Fowlkes J Brian, Gorman Beverly, Huang Pintong, Kono Yuko, Lopez-Mattei Juan, Lyshchik Andrej, Main Michael L, Matthias Wilson, Merrill Christina, Mulvagh Sharon L, Nihoyannopoulos Petros, Olson Joan, Piscaglia Fabio, Porter Thomas, Rabischoffsky Arnaldo, Senior Roxy, Stout Jessica L, Stanczak Maria, Wilson Stephanie R

机构信息

Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, 375 Longwood Avenue, 4Th Floor, Boston, MA, 02215, USA.

International Contrast Ultrasound Society, Chicago, USA.

出版信息

Echo Res Pract. 2025 Feb 21;12(1):4. doi: 10.1186/s44156-024-00068-7.

Abstract

Contrast enhanced ultrasound (CEUS) offers a safe, reliable imaging option to establish a clinical diagnosis across a variety of multidisciplinary settings. This Expert Consensus Statement serves to outline expert opinion on what constitutes appropriate supervision and the essential components of safe CEUS practice. The purpose of this document is to empower institutions to allow sonographers, along with other trained medical professionals, to administer UCAs at the point of care, consistent with the updated scope of practice documentation and within the broad parameters of an individual's training and licensure, while subject to appropriate supervision and meeting or exceeding minimum safety standards. This guidance was developed by the International Contrast Ultrasound Society and endorsed by the following organizations that represent ultrasound professionals: the British Society of Echocardiography, the Canadian Society of Echocardiography, the Society of Diagnostic Medical Sonography, the Society for Pediatric Radiology, the World Federation of Ultrasound in Medicine and Biology, the Brazilian College of Radiology, the Joint Review Committee for Diagnostic Medical Sonography, the Chinese Ultrasound Doctors Association, and the American Society of Neuroimaging. Additionally, this guidance document was affirmed or supported by the American Society of Echocardiography, the Association for Medical Ultrasound, and the Society for Vascular Ultrasound.

摘要

超声造影(CEUS)提供了一种安全、可靠的成像选择,可在各种多学科环境中进行临床诊断。本专家共识声明旨在概述关于适当监督的专家意见以及安全CEUS实践的基本组成部分。本文档的目的是使各机构能够允许超声检查人员以及其他经过培训的医学专业人员在护理点使用超声造影剂,这与更新后的实践范围文件一致,并在个人培训和执照的广泛范围内,同时接受适当监督并达到或超过最低安全标准。本指南由国际超声造影学会制定,并得到以下代表超声专业人员的组织认可:英国超声心动图学会、加拿大超声心动图学会、诊断医学超声学会、儿科放射学会、世界医学和生物学超声联合会、巴西放射学会、诊断医学超声联合审查委员会、中国超声医师协会和美国神经影像学会。此外,本指南文件得到了美国超声心动图学会、医学超声协会和血管超声学会的肯定或支持。

相似文献

4
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).IgE介导的过敏性疾病中变应原特异性免疫治疗指南:德国变态反应学与临床免疫学会(DGAKI)、儿科变态反应与环境医学学会(GPA)、德国变态反应科医生医学协会(AeDA)、奥地利变态反应与免疫学会(ÖGAI)、瑞士变态反应与免疫学会(SGAI)、德国皮肤病学会(DDG)、德国耳鼻咽喉头颈外科学会(DGHNO-KHC)、德国儿科学与青少年医学学会(DGKJ)、儿科肺病学会(GPP)、德国呼吸学会(DGP)、德国耳鼻喉外科医生协会(BV-HNO)、儿科医生与青年医生专业联合会(BVKJ)、肺科医生联邦协会(BDP)以及德国皮肤科医生协会(BVDD)的S2k指南
Allergo J Int. 2014;23(8):282-319. doi: 10.1007/s40629-014-0032-2.
6
Diagnostic Point-of-Care Ultrasound: Recommendations From an Expert Panel.即时诊断床边超声:专家小组的建议。
J Cardiothorac Vasc Anesth. 2022 Jan;36(1):22-29. doi: 10.1053/j.jvca.2021.04.016. Epub 2021 Apr 17.
10
Evidence-based guideline: premature ovarian insufficiency.循证指南:卵巢早衰
Hum Reprod Open. 2024 Dec 9;2024(4):hoae065. doi: 10.1093/hropen/hoae065. eCollection 2024.

本文引用的文献

2
Kounis Syndrome After Administration of Ultrasound Enhancing Agent.超声增强剂给药后发生的库尼综合征。
Circ Cardiovasc Imaging. 2024 Mar;17(3):e016362. doi: 10.1161/CIRCIMAGING.123.016362. Epub 2024 Feb 28.
7
Impact of ultrasound enhancing agents on clinical management.超声增强剂对临床管理的影响。
Curr Opin Cardiol. 2022 Sep 1;37(5):389-393. doi: 10.1097/HCO.0000000000000973.
10
Identification of Need for Ultrasound Enhancing Agent Study (the IN-USE Study).超声增强剂研究需求识别(IN-USE 研究)。
J Am Soc Echocardiogr. 2020 Dec;33(12):1500-1508. doi: 10.1016/j.echo.2020.07.015. Epub 2020 Sep 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验